Your browser doesn't support javascript.
loading
Bile cytology diagnosis in challenging cases: Validation of diagnostic bile cytology criteria and extensive study for immunocytochemical markers.
Sano, Naoki; Tabata, Kenichi; Oda, Tomohiro; Yanagita, Miki; Suzuki, Tomoko; Komatsubara, Toshihide; Kawata, Hirotoshi; Fukushima, Noriyoshi.
Afiliación
  • Sano N; Department of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Tabata K; Department of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Oda T; Department of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Yanagita M; Department of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Suzuki T; Department of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Komatsubara T; Department of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Kawata H; Department of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Fukushima N; Department of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Japan.
Diagn Cytopathol ; 50(3): 123-132, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34981669
BACKGROUND: Bile cytology is useful in diagnosing biliary tract lesions, albeit often challenging due to equivocal findings. To achieve better diagnoses for clinical decisions, we conducted cytomorphological and immunocytochemical studies of bile cytology cases. MATERIALS AND METHODS: We re-evaluated 40 bile cytology cases with initial equivocal diagnoses, taken from the cytology records of Jichi Medical University Hospital, including 1778 bile cytology specimens. First, we assessed the cases by the diagnostic bile cytology criteria of the Japanese Society of Clinical Cytology. Second, we searched for useful immunocytochemical markers by extensive immunohistochemical analyses using tissue microarray for 10 antibodies: S100P, IMP3, GLUT1, p53, S100A4, Mapsin, MUC17, CD10, MDM2, and SMAD4. Microarrays were from 257 extrahepatic bile duct carcinoma cases. To elucidate the utility of immunocytochemistry, we applied selected markers to immunocytochemical evaluation of the equivocal cases after cell transfer. RESULTS: The criteria indicated a sensitivity 60%, specificity 87%, and accuracy 70%. Irregularly overlapping (88%), arranged (96%), and shaped (76%) nuclei were more common in malignant cases, while enlarged nuclei were more frequent in benign cases (67% vs. 28%). We applied S100P and IMP3, which showed higher accuracy (88% and 77%) in tissue microarray, to immunocytochemistry. The sensitivity of S100P and IMP3 were 69% and 70%, respectively. The specificity of S100P and IMP3 were 50% and 100%, respectively. CONCLUSION: The criteria showed a certain effectiveness even in challenging cases, and some pitfalls associated with reactive changes of benign cells. Although comprehensive diagnosis including cytomorphology seems preferable, S100P and IMP3 are promising immunocytochemical markers.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bilis / Neoplasias de los Conductos Biliares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Diagn Cytopathol Asunto de la revista: PATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bilis / Neoplasias de los Conductos Biliares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Diagn Cytopathol Asunto de la revista: PATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos